About the Book
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Pages: 104. Chapters: Alexia (condition), Alzheimer's disease, Angelman syndrome, Anna Gillingham, Asperger syndrome, Auditory processing disorder, Autism, Autism spectrum, Beacon College, Blue Apple Theatre, Center for the Assessment and Remediation of Reading Difficulties, Cerebral palsy, Childhood disintegrative disorder, Deep dyslexia, Dementia, Double deficit (education), Down syndrome, Dyscravia, Dysgraphia, Dyslexia research, Fuzzbuzz, Gateway Academy, Generalist Genes Hypothesis, Greengate School, High-functioning autism, Interdisciplinary Council on Developmental and Learning Disorders, Landmark College, Language-based learning disability, Learning Ally, Learning Disability Coalition, Mild cognitive impairment, Multi-infarct dementia, Nonverbal learning disorder, Oakland School (Virginia), Orton-Gillingham, PDD-NOS, Pervasive developmental disorder, Phonological deficit, Pragmatic language impairment, Primary progressive aphasia, Pure alexia, Reading disability, Reading for special needs, Rett syndrome, Samuel Orton, Shared lives, Specific developmental disorder, Theories of dyslexia, The Gow School, The Lewis School of Princeton, WillowWood School. Excerpt: Alzheimer's disease (AD), also known in medical literature as Alzheimer disease, is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death. It was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Most often, AD is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer's can occur much earlier. In 2006, there were sufferers worldwide. Alzheimer's is predicted to affect 1 in 85 people globally by 2050. Although Alzheimer's disease develops differently for every individual, there are many common symptoms. Early symptoms are often mistakenly thought to be 'age-related' concerns, or manifestations of stress. In the early stages, the most common symptom is difficulty in remembering recent events. When AD is suspected, the diagnosis is usually confirmed with tests that evaluate behaviour and thinking abilities, often followed by a brain scan if available. As the disease advances, symptoms can include confusion, irritability and aggression, mood swings, trouble with language, and long-term memory loss. As the sufferer declines they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Since the disease is different for each individual, predicting how it will affect the person is difficult. AD develops for an unknown and variable amount of time before becoming fully apparent, and it can progress undiagnosed for years. On average, the life expectancy following diagnosis is approximately seven years. Fewer than three percent of individuals live more than fourteen years after diagnosis. The cause and progression of Alzheimer's disease are not well understood. Research indicates that the disease is associated with plaques and tangles in the brain. Current treatments only help with the symptoms of the disease. There are no available treatments that stop or re
